A pilot study to investigate whether fatigue is a side effect of etanercept in patients with moderate to severe psoriasis

A pilot study to investigate whether fatigue is a side effect of etanercept in patients with moderate to severe psoriasis - Pilot study on fatigue as a side effect of etanercept

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON29881

Enrollment

160

Registered

2006-09-22

Start date

2006-08-15

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psoriasis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Adult patients at the outpatient clinic diagnosed psoriasis with a PASI score *10 - Patients selected for treatment with etanercept - Patients selected for treatment with narrowband UVB therapy

Exclusion criteria

Exclusion criteria: - PASI

Design outcomes

Primary

Measure	Time frame
The percentage of patients on etanercept therapy who report fatigue, as identified by three validated questionnaires, compared to a similar group of psoriasis patients receiving phototherapy.	—

Countries

Netherlands

Outcome results